Related Experiment Video
Updated: Jan 18, 2026

07:37
Performing an In Vitro Genome-Wide CRISPR Knockout Screen in Chimeric Antigen Receptor T Cells
Published on: January 31, 2025
1.4K
Mapping kinase-dependent tumor immune adaptation with multiplexed single-cell CRISPR screens
Lingting Shi1,2, Ross M Giglio3, Qingyuan Cai4
1Irving Institute for Cancer Dynamics, Columbia University, New York, NY, 10027, USA.
Biorxiv : the Preprint Server for Biology
|January 16, 2026
Summary
This study maps glioblastoma's (GBM) tumor-intrinsic immune evasion strategies using CRISPR screening. It identifies kinase targets like EPHA2 and PDGFRA that, when inhibited, enhance T cell-mediated killing of GBM tumors.
Area of Science:
- Cancer immunology
- Genomics
- Single-cell analysis
Background:
- Tumor cells employ intrinsic programs to evade immune attack.
- Direct tumor-immune interactions can model these evasion mechanisms in vitro.
Purpose of the Study:
- To map tumor-intrinsic regulation of T cell-driven immune pressure in glioblastoma (GBM).
- To identify genetic perturbations that alter tumor state and adaptive responses to T cell engagement.
Main Methods:
- High-throughput single-cell CRISPR screening (CRISPR interference and activation) focused on the protein kinome.
- Allogeneic GBM-T cell co-culture with immune-matched antigen specificity.
- Massively multiplexed single-cell transcriptomics and deep generative models for data analysis.
Main Results:
- Resolved distinct modules of immune evasion, including antigen presentation, interferon/NF-κB signaling, oxidative stress resilience, and cytokine programs.
- Identified genetic perturbations that alter tumor transcriptional trajectories under T cell pressure.
- Discovered kinase targets (EPHA2, PDGFRA) involved in GBM immune evasion phenotypes.
Conclusions:
- The developed CRISPR screening framework provides a scalable blueprint for dissecting tumor-immune interactions.
- Inhibition of identified kinase targets enhances T cell-mediated killing of glioblastoma.
- This research elucidates genetic control mechanisms underlying tumor immune evasion.

